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To the Editor: In a recent publication, Sinnamon et al.1
showed the images of renal infarction caused by fibro-
muscular dysplasia. Although the authors stated that a
satisfactory radiological result was achieved, we have some
concern about the result of the percutaneous intervention.
The magnetic resonance angiogram shows a branch
feeding the upper pole of the right kidney (arrowhead
no. 1). However, the selective renal angiogram after the
intervention does not show this branch, and the angiographic
intensity of the upper pole is faint (arrowhead no. 2). We
suspect stenosis of the branch for the upper pole, which
would have been better if dilated. Supporting this notion, the
diameter of the branch indicated by the arrowhead no. 3 is
too small to be a primary branch (please compare the
diameter with those of other primary branches). As the
intervention in the case revealed additional branches (please
compare the upper branch in Figures 3 and 5 of Sinnamon
et al.), dilation of the branch (indicated by the arrowhead
no. 3) could have revealed another branches, which might
necessitate intervention.
The angiographic intensity of the lower pole after the
intervention is also faint (arrowhead no. 4), and we think
that the lesion indicated by the arrowhead no. 5 would have
been better if dilated. The disturbance of renal perfusion by
these lesions (arrowheads nos. 3 and 5) could have induced
renovascular hypertension and necessitated antihypertensive
treatment after intervention in the case.2 Improvement of the
renal perfusion by angioplasty for these lesions could have
not only cured hypertension but also preserved more renal
function.3
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The authors would like to thank Tanemoto and colleagues1
for their comments and for highlighting the importance of
a thorough angiographic evaluation by an experienced
practitioner in cases such as these. Following full assess-
ment, other lesions, for example the lesion depicted by
arrowhead no. 5, also underwent intervention. However,
only a limited number of views were submitted for
publication given the constraints of the journal. Following
a complete review of all the images, the interventional
radiology team was satisfied that a good angiographic
result had been achieved. This is reflected in the patient’s
clinical status as she currently has good blood pressure
control on a single agent and essentially normal renal
function despite infarcting approximately 50% of the right
kidney.
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